Pyrimethamine as a Treatment for Late-Onset GM2-gangliosidosis (Tay-Sachs and Sandhoff Disease)
Proposed Investigator-Initiated Clinical Trial of Pyrimethamine as a Treatment for Late-Onset GM2-gangliosidosis (Tay-Sachs and Sandhoff Disease) Proposed Investigator-Initiated Clinical Trial of Pyrimethamineas a Treatment for Late-Onset GM2-gan ...
A Phase I Study of Pyrimethamine in Patients With GM2 Gangliosidosis
A Dose-Escalated, Double-Blind, Placebo-Controlled, Randomized Phase I Clinical Trial of Pyrimethamine in Patients Affected With Chronic GM2 Gangliosidosis (Tay-Sachs or Sandhoff Variants) A Dose-Escalated, Double-Blind, Placebo-Controlled, Randomized Phase I Clinical Trial of Pyrimethami ...
University Hospital Case Medical Center;New York University School of Medicine;The Hospital for Sick Children University Hospital Case Medical Center;New York University School of Medicine;The Hospital for Sick ...